US Stock MarketDetailed Quotes

Amicus Therapeutics (Delisted) (FOLD)

Watchlist
  • 14.490
  • 0.0000.00%
Close Apr 24 16:00 ET
4.55BMarket Cap-161.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amicus Therapeutics (Delisted) (FOLD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
20.05%634.21M
23.72%185.21M
19.46%169.06M
22.12%154.69M
13.45%125.25M
32.29%528.3M
30.09%149.71M
36.73%141.52M
34.04%126.67M
27.97%110.4M
Operating revenue
20.05%634.21M
23.72%185.21M
19.46%169.06M
22.12%154.69M
13.45%125.25M
32.29%528.3M
30.09%149.71M
36.73%141.52M
34.04%126.67M
27.97%110.4M
Cost of revenue
37.75%72.93M
78.94%26.55M
46.60%19.47M
35.13%15.22M
-13.78%11.7M
41.84%52.94M
31.01%14.84M
33.51%13.28M
23.56%11.26M
95.43%13.57M
Gross profit
18.08%561.28M
17.64%158.67M
16.65%149.59M
20.85%139.47M
17.26%113.55M
31.30%475.35M
29.99%134.87M
37.07%128.24M
35.16%115.41M
22.07%96.84M
Operating expense
19.38%526.79M
20.03%142.72M
11.49%115.33M
46.60%147.24M
2.52%121.5M
1.32%441.29M
10.66%118.9M
-4.74%103.44M
-2.27%100.44M
1.54%118.51M
Selling and administrative expenses
18.59%383.49M
35.09%117.08M
19.88%90.04M
14.91%84.54M
4.31%91.83M
17.48%323.38M
23.39%86.67M
14.40%75.11M
12.46%73.58M
19.03%88.03M
Research and development costs
24.21%135.84M
-21.36%23.74M
-10.49%23.42M
146.52%60.85M
-1.73%27.84M
-28.23%109.36M
-13.81%30.19M
-35.73%26.16M
-29.78%24.68M
-31.74%28.33M
Depreciation amortization depletion
-12.72%7.46M
-7.06%1.9M
-13.64%1.87M
-15.12%1.85M
-14.72%1.84M
8.56%8.55M
-6.46%2.04M
-2.60%2.17M
-1.09%2.18M
71.36%2.15M
-Depreciation and amortization
-12.72%7.46M
-7.06%1.9M
-13.64%1.87M
-15.12%1.85M
-14.72%1.84M
8.56%8.55M
-6.46%2.04M
-2.60%2.17M
-1.09%2.18M
71.36%2.15M
Operating profit
1.25%34.49M
-0.16%15.95M
38.17%34.27M
-151.93%-7.77M
63.31%-7.95M
146.35%34.06M
532.58%15.97M
265.04%24.8M
186.07%14.97M
42.02%-21.68M
Net non-operating interest income expense
3.05%-42.84M
-0.50%-10.6M
6.28%-10.88M
3.77%-10.72M
2.32%-10.64M
-2.60%-44.19M
5.50%-10.54M
-0.83%-11.61M
-3.60%-11.14M
-12.97%-10.9M
Non-operating interest income
-38.65%3.32M
-41.17%833K
-23.31%829K
-38.47%843K
-47.27%812K
-23.61%5.41M
-15.26%1.42M
-26.51%1.08M
-21.13%1.37M
-29.97%1.54M
Non-operating interest expense
-6.93%46.16M
-4.43%11.43M
-7.73%11.71M
-7.57%11.57M
-7.89%11.46M
-1.10%49.6M
-6.77%11.96M
-2.26%12.69M
0.16%12.51M
5.00%12.44M
Other net income (expense)
145.85%8.54M
-188.14%-2.21M
269.95%10.89M
81.52%-687K
105.00%550K
44.45%-18.63M
114.90%2.51M
-448.53%-6.41M
69.96%-3.72M
-77.91%-11.01M
Special income (charges)
81.48%-1.7M
--0
--0
---1.7M
--0
47.94%-9.19M
--0
-57.54%-3.14M
--0
-2,308.37%-6.05M
-Less：Restructuring and merger&acquisition
--0
--0
--0
--0
--0
255.71%9.19M
--0
57.54%3.14M
--0
2,308.37%6.05M
-Write off
--1.7M
--0
--0
--1.7M
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
208.51%10.24M
-188.14%-2.21M
433.65%10.89M
127.31%1.02M
111.08%550K
40.57%-9.44M
187.01%2.51M
-185.13%-3.26M
65.91%-3.72M
16.37%-4.97M
Income before tax
100.66%191K
-60.39%3.14M
405.14%34.27M
-17,860.19%-19.18M
58.60%-18.05M
80.84%-28.76M
125.06%7.93M
127.46%6.79M
100.27%108K
18.11%-43.58M
Income tax
-0.18%27.3M
121.35%1.45M
25.56%16.97M
-66.85%5.24M
-24.71%3.64M
1,744.23%27.35M
-411.73%-6.81M
532.03%13.51M
482.14%15.81M
1,785.02%4.84M
Net income
51.68%-27.11M
-88.53%1.69M
357.19%17.31M
-55.57%-24.42M
55.21%-21.69M
62.99%-56.11M
143.55%14.74M
68.81%-6.73M
63.69%-15.7M
8.53%-48.42M
Net income continuous Operations
51.68%-27.11M
-88.53%1.69M
357.19%17.31M
-55.57%-24.42M
55.21%-21.69M
62.99%-56.11M
143.55%14.74M
68.81%-6.73M
63.69%-15.7M
8.53%-48.42M
Minority interest income
Net income attributable to the parent company
51.68%-27.11M
-88.53%1.69M
357.19%17.31M
-55.57%-24.42M
55.21%-21.69M
62.99%-56.11M
143.55%14.74M
68.81%-6.73M
63.69%-15.7M
8.53%-48.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
51.68%-27.11M
-88.53%1.69M
357.19%17.31M
-55.57%-24.42M
55.21%-21.69M
62.99%-56.11M
143.55%14.74M
68.81%-6.73M
63.69%-15.7M
8.53%-48.42M
Basic earnings per share
50.00%-0.09
0
400.00%0.06
-60.00%-0.08
56.25%-0.07
64.71%-0.18
145.45%0.05
71.43%-0.02
66.67%-0.05
11.11%-0.16
Diluted earnings per share
50.00%-0.09
0
400.00%0.06
-60.00%-0.08
56.25%-0.07
64.71%-0.18
145.45%0.05
71.43%-0.02
66.67%-0.05
11.11%-0.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 20.05%634.21M23.72%185.21M19.46%169.06M22.12%154.69M13.45%125.25M32.29%528.3M30.09%149.71M36.73%141.52M34.04%126.67M27.97%110.4M
Operating revenue 20.05%634.21M23.72%185.21M19.46%169.06M22.12%154.69M13.45%125.25M32.29%528.3M30.09%149.71M36.73%141.52M34.04%126.67M27.97%110.4M
Cost of revenue 37.75%72.93M78.94%26.55M46.60%19.47M35.13%15.22M-13.78%11.7M41.84%52.94M31.01%14.84M33.51%13.28M23.56%11.26M95.43%13.57M
Gross profit 18.08%561.28M17.64%158.67M16.65%149.59M20.85%139.47M17.26%113.55M31.30%475.35M29.99%134.87M37.07%128.24M35.16%115.41M22.07%96.84M
Operating expense 19.38%526.79M20.03%142.72M11.49%115.33M46.60%147.24M2.52%121.5M1.32%441.29M10.66%118.9M-4.74%103.44M-2.27%100.44M1.54%118.51M
Selling and administrative expenses 18.59%383.49M35.09%117.08M19.88%90.04M14.91%84.54M4.31%91.83M17.48%323.38M23.39%86.67M14.40%75.11M12.46%73.58M19.03%88.03M
Research and development costs 24.21%135.84M-21.36%23.74M-10.49%23.42M146.52%60.85M-1.73%27.84M-28.23%109.36M-13.81%30.19M-35.73%26.16M-29.78%24.68M-31.74%28.33M
Depreciation amortization depletion -12.72%7.46M-7.06%1.9M-13.64%1.87M-15.12%1.85M-14.72%1.84M8.56%8.55M-6.46%2.04M-2.60%2.17M-1.09%2.18M71.36%2.15M
-Depreciation and amortization -12.72%7.46M-7.06%1.9M-13.64%1.87M-15.12%1.85M-14.72%1.84M8.56%8.55M-6.46%2.04M-2.60%2.17M-1.09%2.18M71.36%2.15M
Operating profit 1.25%34.49M-0.16%15.95M38.17%34.27M-151.93%-7.77M63.31%-7.95M146.35%34.06M532.58%15.97M265.04%24.8M186.07%14.97M42.02%-21.68M
Net non-operating interest income expense 3.05%-42.84M-0.50%-10.6M6.28%-10.88M3.77%-10.72M2.32%-10.64M-2.60%-44.19M5.50%-10.54M-0.83%-11.61M-3.60%-11.14M-12.97%-10.9M
Non-operating interest income -38.65%3.32M-41.17%833K-23.31%829K-38.47%843K-47.27%812K-23.61%5.41M-15.26%1.42M-26.51%1.08M-21.13%1.37M-29.97%1.54M
Non-operating interest expense -6.93%46.16M-4.43%11.43M-7.73%11.71M-7.57%11.57M-7.89%11.46M-1.10%49.6M-6.77%11.96M-2.26%12.69M0.16%12.51M5.00%12.44M
Other net income (expense) 145.85%8.54M-188.14%-2.21M269.95%10.89M81.52%-687K105.00%550K44.45%-18.63M114.90%2.51M-448.53%-6.41M69.96%-3.72M-77.91%-11.01M
Special income (charges) 81.48%-1.7M--0--0---1.7M--047.94%-9.19M--0-57.54%-3.14M--0-2,308.37%-6.05M
-Less：Restructuring and merger&acquisition --0--0--0--0--0255.71%9.19M--057.54%3.14M--02,308.37%6.05M
-Write off --1.7M--0--0--1.7M------0--0--0--0----
Other non- operating income (expenses) 208.51%10.24M-188.14%-2.21M433.65%10.89M127.31%1.02M111.08%550K40.57%-9.44M187.01%2.51M-185.13%-3.26M65.91%-3.72M16.37%-4.97M
Income before tax 100.66%191K-60.39%3.14M405.14%34.27M-17,860.19%-19.18M58.60%-18.05M80.84%-28.76M125.06%7.93M127.46%6.79M100.27%108K18.11%-43.58M
Income tax -0.18%27.3M121.35%1.45M25.56%16.97M-66.85%5.24M-24.71%3.64M1,744.23%27.35M-411.73%-6.81M532.03%13.51M482.14%15.81M1,785.02%4.84M
Net income 51.68%-27.11M-88.53%1.69M357.19%17.31M-55.57%-24.42M55.21%-21.69M62.99%-56.11M143.55%14.74M68.81%-6.73M63.69%-15.7M8.53%-48.42M
Net income continuous Operations 51.68%-27.11M-88.53%1.69M357.19%17.31M-55.57%-24.42M55.21%-21.69M62.99%-56.11M143.55%14.74M68.81%-6.73M63.69%-15.7M8.53%-48.42M
Minority interest income
Net income attributable to the parent company 51.68%-27.11M-88.53%1.69M357.19%17.31M-55.57%-24.42M55.21%-21.69M62.99%-56.11M143.55%14.74M68.81%-6.73M63.69%-15.7M8.53%-48.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 51.68%-27.11M-88.53%1.69M357.19%17.31M-55.57%-24.42M55.21%-21.69M62.99%-56.11M143.55%14.74M68.81%-6.73M63.69%-15.7M8.53%-48.42M
Basic earnings per share 50.00%-0.090400.00%0.06-60.00%-0.0856.25%-0.0764.71%-0.18145.45%0.0571.43%-0.0266.67%-0.0511.11%-0.16
Diluted earnings per share 50.00%-0.090400.00%0.06-60.00%-0.0856.25%-0.0764.71%-0.18145.45%0.0571.43%-0.0266.67%-0.0511.11%-0.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.00%
Sample Name
Sample Code
 +12.40%
Sample Name
Sample Code
 +11.01%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.22%
5
United States Oil Fund LP
USO
+7.03%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.20%
Sample Name
Sample Code
 +18.16%
Sample Name
Sample Code
 +12.05%
4
KE Holdings
BEKE
+10.61%
5
ASE Technology
ASX
+8.36%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -